Unique ID issued by UMIN | UMIN000025996 |
---|---|
Receipt number | R000029884 |
Scientific Title | A study for evaluating the effect of the intake of the test products on postprandial hyperglycemia for healthy male |
Date of disclosure of the study information | 2017/02/03 |
Last modified on | 2017/05/29 09:15:30 |
A study for evaluating the effect of the intake of the test products on postprandial hyperglycemia for healthy male
A study for evaluating the effect of the intake of the test products on postprandial hyperglycemia for healthy male
A study for evaluating the effect of the intake of the test products on postprandial hyperglycemia for healthy male
A study for evaluating the effect of the intake of the test products on postprandial hyperglycemia for healthy male
Japan |
Healthy male
Adult |
Others
NO
To investigate the effect of the test products on postprandial hyperglycemia.
Efficacy
Incremental area under the curve of plasma glucose
Peak in plasma glucose concentration, fasting plasma glucose , plasma glucose at 15, 30, 45, 60, 90, and 120 min.
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Food |
Intake of the standard products,Intake of the test products
20 | years-old | <= |
50 | years-old | >= |
Male
(1)Males from 20 to 50 years of age.
(2)Subjects who have a difference of incremental area under the curve of plasma glucose levels between preliminary examination 1 and preliminary examination 2 within 25 percent.
(1)Subjects routinely taking medicine or health food which may influence glucose metabolism.
(2)Subjects who have abnormal glucose tolerance within the one month prior on preliminary examination.
(3)Subjects who have body mass index (BMI) less than 18.5 kg per square meter or more than 25.0 kg per square meter.
(4)Subjects who have abnormal glucose tolerance on preliminary examination
(5)Subjects who work at night or have irregular life more than one time in the study.
(6)Subjects who are planning to go overseas.
(7)Subjects with allergies to the test food in the study.
(8)Subjects who drink alcohol a lot.
(9)Subjects who smoke a lot.
(10)Subjects who has serious illness such as diabetes, liver disease, kidney disease, heart disease, digestive system disease.
(11)Subjects who have a disease under medication or having a history of study such as obesity, dyslipidemia, hypertension or who has a serious disease.
(12)Subject who are judged as unsuitable for the study from clinical measurements for preliminary tests and measurements.
(13)Subjects who have participated in other clinical study within the last one month or have planned to participate other clinical studies.
(14)Subjects who are judged as unsuitable for the study from questionnaire.
(15)Subjects who are judged as ineligible by clinical investigator.
12
1st name | |
Middle name | |
Last name | Shigeki Satomi |
House Foods Co., Ltd
Research & Development institute
1-4, Takanodai, Yotsukaido, Chiba
043-237-5211
s-satomi@housefoods.co.jp
1st name | |
Middle name | |
Last name | Noriko Watanabe |
TTC Co.,Ltd.
Clinical Research Planning Department
1-20-2, Ebisunishi, Shibuya-ku, Tokyo
03-5459-5329
n.watanabe@ttc-tokyo.co.jp
TTC Co.,Ltd.
House Foods Co., Ltd
Profit organization
NO
2017 | Year | 02 | Month | 03 | Day |
Unpublished
Completed
2017 | Year | 01 | Month | 26 | Day |
2017 | Year | 02 | Month | 04 | Day |
2017 | Year | 02 | Month | 03 | Day |
2017 | Year | 05 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029884